Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 01 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-1.02 Insider Own25.65% Shs Outstand95.93M Perf Week4.75%
Market Cap507.47M Forward P/E- EPS next Y-0.20 Insider Trans0.00% Shs Float71.32M Perf Month42.97%
Income-70.80M PEG- EPS next Q-0.04 Inst Own33.21% Short Float / Ratio1.29% / 1.87 Perf Quarter50.28%
Sales0.00M P/S- EPS this Y17.55% Inst Trans-3.47% Short Interest0.92M Perf Half Y72.88%
Book/sh2.31 P/B2.29 EPS next Y6.45% ROA-27.34% Target Price11.71 Perf Year62.77%
Cash/sh2.44 P/C2.17 EPS next 5Y- ROE-32.38% 52W Range1.40 - 6.99 Perf YTD130.00%
Dividend- P/FCF- EPS past 5Y-68.83% ROI-31.22% 52W High-24.32% Beta-0.78
Dividend %- Quick Ratio7.73 Sales past 5Y-25.00% Gross Margin- 52W Low277.86% ATR0.50
Employees314 Current Ratio7.73 Sales Q/Q- Oper. Margin0.00% RSI (14)64.66 Volatility16.84% 12.18%
OptionableYes Debt/Eq0.07 EPS Q/Q70.00% Profit Margin- Rel Volume0.52 Prev Close4.87
ShortableYes LT Debt/Eq0.02 EarningsNov 13 BMO Payout- Avg Volume494.36K Price5.29
Recom1.00 SMA2014.35% SMA5047.76% SMA20068.98% Volume257,122 Change8.62%
Date Action Analyst Rating Change Price Target Change
Nov-27-23Initiated Evercore ISI Outperform
Oct-19-23Initiated Stifel Buy $11
Mar-27-23Resumed Wells Fargo Overweight $7
Dec-08-22Initiated H.C. Wainwright Buy $6
Sep-22-22Initiated Citigroup Buy $12
Aug-18-22Resumed Wells Fargo Overweight
Jun-01-22Initiated Cantor Fitzgerald Overweight $20
Apr-04-22Initiated BTIG Research Buy $18
Feb-03-21Initiated Citigroup Buy $35
Feb-02-21Initiated Wells Fargo Overweight $33
Nov-27-23 08:00AM
Nov-23-23 12:00PM
Nov-16-23 08:00AM
Nov-14-23 01:03AM
07:30AM Loading…
Nov-13-23 07:30AM
Nov-09-23 08:36AM
Nov-08-23 08:30AM
Nov-02-23 09:00AM
Nov-01-23 04:00PM
Oct-31-23 09:00AM
Oct-30-23 02:02PM
Sep-27-23 08:30AM
04:00PM Loading…
Sep-26-23 04:00PM
Sep-19-23 09:21AM
Sep-14-23 09:15AM
Sep-12-23 09:55AM
Sep-06-23 08:00AM
Aug-24-23 04:10PM
Aug-21-23 09:02PM
Aug-15-23 12:51AM
Aug-14-23 07:15AM
Aug-07-23 02:12PM
Jul-31-23 04:02PM
Jun-20-23 08:30AM
Jun-14-23 11:45AM
03:29PM Loading…
Jun-13-23 03:29PM
Jun-10-23 10:30AM
Jun-03-23 02:15PM
May-24-23 04:01PM
May-16-23 12:12AM
May-15-23 09:15AM
May-11-23 04:00PM
May-10-23 04:19PM
May-02-23 04:00PM
Apr-26-23 10:15AM
Apr-25-23 04:13PM
Mar-22-23 04:10PM
Mar-14-23 12:27AM
Mar-13-23 07:30AM
Feb-28-23 08:00AM
Feb-27-23 08:00AM
Feb-26-23 09:10AM
Feb-14-23 08:46AM
Feb-13-23 07:30AM
Feb-03-23 07:30AM
Jan-16-23 06:23AM
Dec-12-22 10:39AM
Dec-10-22 06:15PM
Dec-08-22 01:28PM
Nov-23-22 08:00AM
Nov-16-22 08:00AM
Nov-14-22 07:15AM
Nov-03-22 09:10AM
Oct-31-22 09:00AM
Oct-24-22 09:00AM
Oct-17-22 08:05AM
Sep-14-22 08:30AM
Aug-29-22 09:00AM
Aug-15-22 07:15AM
Aug-08-22 09:46AM
Aug-02-22 09:00AM
Aug-01-22 08:00AM
Jul-26-22 08:30AM
Jul-19-22 08:00AM
Jun-14-22 08:00AM
Jun-13-22 10:12AM
Jun-12-22 08:00AM
Jun-03-22 11:00AM
May-26-22 05:01PM
May-19-22 08:30AM
May-16-22 07:30AM
May-12-22 10:01AM
May-04-22 08:30AM
May-02-22 08:00AM
Apr-28-22 10:30AM
Apr-22-22 05:00PM
Apr-14-22 08:30AM
Apr-08-22 04:00PM
Mar-29-22 08:30AM
Mar-14-22 07:30AM
Mar-10-22 04:30PM
Mar-08-22 04:30PM
Mar-02-22 08:00AM
Mar-01-22 09:03AM
Feb-22-22 07:30AM
Feb-17-22 08:30AM
Feb-03-22 08:00AM
Jan-18-22 08:00AM
Jan-12-22 08:00AM
Dec-25-21 02:38AM
Dec-16-21 08:00AM
Nov-23-21 09:00AM
Nov-19-21 07:07AM
Gracell Biotechnologies, Inc. is a clinical-stage biopharmaceutical company. It engages in the business of discovering and developing cell therapies to resolve industry challenges and fulfill unmet medical needs in the treatment of cancer. The company was founded by Wei Cao in May 2017 and is headquartered in Suzhou, China.